Economiic Home Method Watch Market RSI Search

Kamada Ltd. KMDA

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Description:

Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; VARIZIG for post exposure prophylaxis of varicella; and GLASSIA for intravenous AATD. It also provides KamRho (D) IM for prophylaxis of hemolytic disease of newborns; KamRho (D) IV for immune thermobocytopunic purpura; and snake bite antiserum to treat snake bites by the vipera palaestinae and echis coloratus. In addition, the company distributes BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN for Allergic rhinitis and Urticaria; IVIG for immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for hepatitis B; MEGALOTECT CP for cytomegalovirus virus; RUCONEST for angioedema attacks; heparin sodium injection for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. Further, it offers IXIARO for Japanese encephalitis; VIVOTIF for Salmonella Typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis ; and ELIGARD for prostate cancer. The company markets its products through strategic partners in the United States, as well as through distributors internationally. Kamada Ltd. has strategic partnerships with Takeda Pharmaceuticals Company Limited; PARI GmbH; and Kedrion Biopharma. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.
Kamada Ltd. website

Recent Quarter:

2024-11-13

Upcoming Quarter:

2025-03-04

Annual Reports

Date2024-03-06
Revenue 144,758,789
Net Income 8,284,000
EPS 0.17
Basic Shares 48,830,479
Diluted Shares 53,675,514
Report Link
Date2023-03-15
Revenue 129,339,000
Net Income -2,321,000
EPS -0.0518
Basic Shares 44,815,248
Diluted Shares 44,815,248
Report Link
Date2022-03-15
Revenue 103,642,000
Net Income -2,230,000
EPS -0.0498
Basic Shares 44,771,766
Diluted Shares 44,771,766
Report Link
Date2021-02-24
Revenue 133,246,000
Net Income 17,140,000
EPS 0.42
Basic Shares 44,140,771
Diluted Shares 44,589,878
Report Link
Date2020-02-26
Revenue 127,187,000
Net Income 22,251,000
EPS 0.57
Basic Shares 40,320,888
Diluted Shares 40,581,627
Report Link
Date2019-02-27
Revenue 114,469,000
Net Income 22,296,000
EPS 0.55
Basic Shares 40,275,374
Diluted Shares 40,538,182
Report Link
Date2018-03-06
Revenue 102,825,000
Net Income 6,901,000
EPS 0.18
Basic Shares 37,970,697
Diluted Shares 38,045,097
Report Link
Date2017-03-01
Revenue 77,494,000
Net Income -6,733,000
EPS -0.18
Basic Shares 36,418,833
Diluted Shares 36,427,373
Report Link
Date2016-02-25
Revenue 70,113,000
Net Income -11,270,000
EPS -0.31
Basic Shares 36,245,813
Diluted Shares 36,245,813
Report Link
Date2015-04-28
Revenue 71,925,000
Net Income -12,636,000
EPS -0.35
Basic Shares 35,710,810
Diluted Shares 35,971,335
Report Link
Date2014-03-26
Revenue 70,623,000
Net Income 443,000
EPS 0.01
Basic Shares 32,714,631
Diluted Shares 33,385,651
Report Link
Date2012-12-31
Revenue 72,675,000
Net Income 260,000
EPS 0.01
Basic Shares 28,078,996
Diluted Shares 28,686,636
Report Link
Date2011-12-31
Revenue 55,920,914
Net Income -3,492,905.937,993
EPS -0.13
Basic Shares 27,550,643
Diluted Shares 27,703,331
Report Link
Date2010-12-31
Revenue 36,274,341
Net Income -15,173,098.007,604
EPS -0.61
Basic Shares 25,058,666
Diluted Shares 25,058,666
Report Link
Date2009-12-31
Revenue 14,979,712
Net Income -22,034,113.07,844
EPS -0.88
Basic Shares 25,058,666
Diluted Shares 25,058,666
Report Link
Date2008-12-31
Revenue 15,213,593
Net Income -12,446,380.289,619
EPS -0.94
Basic Shares 13,196,359
Diluted Shares 13,196,359
Report Link
Date2007-12-31
Revenue 13,437,194
Net Income -22,895,697.120,434
EPS -2.16
Basic Shares 10,610,697
Diluted Shares 10,610,697
Report Link

Annual Ratios

Date2023-12-31
PE 36.07
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -77.43
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -132.11
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE 16.69
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE 12.38
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-12-31
PE 9.03
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-12-31
PE 26.41
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2016-12-31
PE -29.48
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2015-12-31
PE -13.33
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2014-12-31
PE -10.74
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2013-12-31
PE 1098.12
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2012-12-31
PE 1090.76
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2011-12-31
PE -79.66
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2010-12-31
PE -16.68
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2009-12-31
PE -11.49
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2008-12-31
PE -10.71
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2007-12-31
PE -4.68
Dividend Yield 0.00
Payout Ratio: 0.000%

Quarterly Reports

Date2024-08-14
Revenue 41,877,208
Net Income 4,426,000
EPS 0.08
Basic Shares 55,325,000
Diluted Shares 55,325,000
Report Link
Date2024-03-06
Revenue 37,398,285
Net Income 2,365,000
EPS 0.0408
Basic Shares 57,474,400
Diluted Shares 57,474,400
Report Link
Date2024-03-06
Revenue 38,350,244
Net Income 5,058,000
EPS 0.0926
Basic Shares 57,479,528
Diluted Shares 57,479,528
Report Link
Date2023-11-13
Revenue 37,934,000
Net Income 3,223,000
EPS 0.0686
Basic Shares 46,042,857
Diluted Shares 53,716,666
Report Link
Date2023-08-16
Revenue 37,443,000
Net Income 1,812,000
EPS 0.0397
Basic Shares 44,837,310
Diluted Shares 44,837,310
Report Link
Date2023-03-15
Revenue 30,710,000
Net Income -1,809,000
EPS -0.0403
Basic Shares 44,832,840
Diluted Shares 44,832,840
Report Link
Date2023-03-15
Revenue 45,439,000
Net Income 2,944,000
EPS 0.0651
Basic Shares 44,832,843
Diluted Shares 44,832,843
Report Link
Date2022-09-30
Revenue 32,217,000
Net Income 484,000
EPS 0.01
Basic Shares 48,400,000
Diluted Shares 48,400,000
Report Link
Date2022-05-17
Revenue 23,590,000
Net Income -3,921,000
EPS -0.09
Basic Shares 43,566,666
Diluted Shares 43,566,667
Report Link
Date2022-03-15
Revenue 28,093,000
Net Income -1,828,000
EPS -0.0408
Basic Shares 44,799,790
Diluted Shares 45,700,000
Report Link
Date2022-03-15
Revenue 31,469,000
Net Income -5,009,000
EPS -0.11
Basic Shares 44,799,794
Diluted Shares 45,536,364
Report Link
Date2021-11-22
Revenue 23,034,000
Net Income -845,000
EPS -0.02
Basic Shares 42,250,000
Diluted Shares 42,250,000
Report Link
Date2021-11-22
Revenue 24,239,000
Net Income 937,000
EPS 0.02
Basic Shares 44,742,960
Diluted Shares 46,850,000
Report Link
Date2021-02-10
Revenue 24,900,000
Net Income 2,687,000
EPS 0.06
Basic Shares 44,742,960
Diluted Shares 44,783,333
Report Link
Date2020-11-12
Revenue 31,542,000
Net Income 1,629,000
EPS 0.04
Basic Shares 40,725,000
Diluted Shares 40,725,000
Report Link
Date2020-08-12
Revenue 35,325,000
Net Income 6,835,000
EPS 0.15
Basic Shares 45,566,666
Diluted Shares 45,566,667
Report Link
Date2020-05-18
Revenue 33,089,000
Net Income 3,458,000
EPS 0.1
Basic Shares 34,580,000
Diluted Shares 34,580,000
Report Link
Date2020-02-12
Revenue 33,290,000
Net Income 5,218,000
EPS 0.12
Basic Shares 43,483,333
Diluted Shares 43,483,333
Report Link
Date2019-11-13
Revenue 32,071,000
Net Income 5,362,000
EPS 0.13
Basic Shares 41,246,153
Diluted Shares 41,246,154
Report Link
Date2019-11-13
Revenue 33,066,000
Net Income 5,823,000
EPS 0.14
Basic Shares 41,592,857
Diluted Shares 41,592,857
Report Link
Date2019-07-31
Revenue 35,253,000
Net Income 6,143,000
EPS 0.15
Basic Shares 40,953,333
Diluted Shares 40,953,333
Report Link
Date2019-04-16
Revenue 26,797,000
Net Income 4,923,000
EPS 0.12
Basic Shares 41,025,000
Diluted Shares 41,025,000
Report Link
Date2019-02-27
Revenue 48,211,000
Net Income 17,745,000
EPS 0.44
Basic Shares 40,329,545
Diluted Shares 40,329,545
Report Link
Date2018-10-22
Revenue 14,975,000
Net Income -2,391,000
EPS -0.06
Basic Shares 39,850,000
Diluted Shares 39,850,000
Report Link
Date2018-07-10
Revenue 33,842,000
Net Income 5,686,000
EPS 0.14
Basic Shares 40,614,285
Diluted Shares 40,614,286
Report Link
Date2018-04-23
Revenue 17,441,000
Net Income 1,256,000
EPS 0.03
Basic Shares 41,866,666
Diluted Shares 41,866,667
Report Link
Date2018-03-06
Revenue 35,710,000
Net Income 6,252,000
EPS 0.16
Basic Shares 40,261,046
Diluted Shares 40,333,565
Report Link
Date2017-10-26
Revenue 22,918,000
Net Income -236,000
EPS -0.0059
Basic Shares 40,254,740
Diluted Shares 40,254,740
Report Link
Date2017-07-20
Revenue 32,549,000
Net Income 4,862,000
EPS 0.13
Basic Shares 37,400,000
Diluted Shares 37,400,000
Report Link
Date2017-05-16
Revenue 11,648,000
Net Income -3,977,000
EPS -0.11
Basic Shares 36,154,545
Diluted Shares 36,154,545
Report Link
Date2017-03-01
Revenue 24,258,000
Net Income -1,808,000
EPS -0.0496
Basic Shares 36,419,107
Diluted Shares 36,457,377
Report Link
Date2016-10-06
Revenue 19,373,000
Net Income -1,041,000
EPS -0.03
Basic Shares 34,699,966
Diluted Shares 34,700,000
Report Link
Date2016-07-20
Revenue 19,066,000
Net Income -1,585,000
EPS -0.04
Basic Shares 39,625,000
Diluted Shares 39,625,000
Report Link
Date2016-04-06
Revenue 14,797,000
Net Income -2,299,000
EPS -0.06
Basic Shares 38,316,666
Diluted Shares 38,316,667
Report Link
Date2016-02-25
Revenue 25,868,000
Net Income 988,000
EPS 0.03
Basic Shares 36,418,741
Diluted Shares 36,418,741
Report Link
Date2015-10-16
Revenue 16,069,000
Net Income -4,622,000
EPS -0.13
Basic Shares 35,553,846
Diluted Shares 35,553,846
Report Link
Date2015-07-01
Revenue 19,246,000
Net Income -2,342,000
EPS -0.06
Basic Shares 39,033,333
Diluted Shares 39,033,333
Report Link
Date2015-04-01
Revenue 8,930,000
Net Income -5,294,000
EPS -0.15
Basic Shares 35,293,333
Diluted Shares 35,293,333
Report Link
Date2015-04-28
Revenue 25,791,000
Net Income 1,745,000
EPS 0.0485
Basic Shares 35,984,299
Diluted Shares 37,324,697
Report Link
Date2014-10-06
Revenue 17,150,000
Net Income -2,897,000
EPS -0.09
Basic Shares 32,188,888
Diluted Shares 32,188,889
Report Link
Date2014-08-14
Revenue 15,797,000
Net Income -8,362,000
EPS -0.23
Basic Shares 36,356,521
Diluted Shares 36,356,522
Report Link
Date2014-04-03
Revenue 13,187,000
Net Income -3,122,000
EPS -0.09
Basic Shares 34,688,888
Diluted Shares 34,688,889
Report Link
Date2014-03-26
Revenue 24,432,000
Net Income 1,551,000
EPS 0.04
Basic Shares 35,863,463
Diluted Shares 36,179,510
Report Link
Date2013-10-23
Revenue 17,480,000
Net Income 37,000
EPS 0.0013
Basic Shares 35,959,670
Diluted Shares 35,959,670
Report Link
Date2013-07-10
Revenue 16,115,000
Net Income 890,000
EPS -0.03
Basic Shares 35,194,598
Diluted Shares 35,194,598
Report Link
Date2013-06-25
Revenue 12,596,000
Net Income -2,035,000
EPS -0.07
Basic Shares 29,071,428
Diluted Shares 29,071,429
Report Link
Date2012-12-31
Revenue 21,643,000
Net Income 2,858,000
EPS 0.0993
Basic Shares 28,770,000
Diluted Shares 28,770,000
Report Link
Date2012-09-30
Revenue 17,678,000
Net Income 103,000
EPS 0.0037
Basic Shares 27,862,500
Diluted Shares 27,862,500
Report Link
Date2012-06-30
Revenue 13,752,000
Net Income -2,229,000
EPS -0.08
Basic Shares 27,862,500
Diluted Shares 27,862,500
Report Link

Quarterly Ratios

Date2024-06-30
PE 15.09
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-03-31
PE 34.08
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-12-31
PE 17.39
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-09-30
PE 19.07
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-06-30
PE 32.63
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-03-31
PE -28.78
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE 15.27
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-09-30
PE 112.75
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-06-30
PE -12.53
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-03-31
PE -33.82
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -14.71
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-09-30
PE -66.25
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-06-30
PE 69.48
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-03-31
PE 25.77
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE 40.50
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-09-30
PE 13.93
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-06-30
PE 19.40
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-03-31
PE 12.15
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE 13.13
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-09-30
PE 9.16
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-06-30
PE 9.18
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-03-31
PE 11.69
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-12-31
PE 2.84
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-09-30
PE -26.00
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-06-30
PE 9.29
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-03-31
PE 36.67
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-12-31
PE 7.73
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-09-30
PE -204.69
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-06-30
PE 11.54
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-03-31
PE -15.45
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2016-12-31
PE -27.45
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2016-09-30
PE -42.75
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2016-06-30
PE -22.94
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2016-03-31
PE -15.94
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2015-12-31
PE 38.21
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2015-09-30
PE -6.58
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2015-06-30
PE -15.92
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2015-03-31
PE -7.37
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2014-12-31
PE 19.59
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2014-09-30
PE -12.39
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2014-06-30
PE -7.75
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2014-03-31
PE -40.28
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2013-12-31
PE 85.96
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2013-09-30
PE 3717.45
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2013-06-30
PE 116.95
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2013-03-31
PE -36.07
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2012-12-31
PE 25.42
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2012-09-30
PE 683.04
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2012-06-30
PE -31.56
Dividend Yield 0.00
Payout Ratio: 0.000%

RSI:

38.74

Price:

$5.82

Market Cap:

334,566,192

EPS TTM:

0.28

PE Ratio:

21.36

PEPSG:

NaN

Fwd PE:

NaN

Volume:

35,031

2 Year Price Change

1.302

Index 2 Year Price Change

1.497

5 Year Price Change

0.852

Index 5 Year Price Change

1.905
PESPG: Growth Rate of EPS projected to next quarter and 6 months trailing. Lower is better to help calculate nexts quarters PE Ratio today. Diluted shares effects the EPS reported and makes calculation show as extremely poor expected growth.

Revenue

Net Income

EPS

Shares

News

Press Releases

Notable Earnings

Please select an option: